Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Singer

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Federation Proceedings|April 1, 1984
Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907M J Ryan, D M Boucher, D M Cohen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1986
CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4-imidazolinedione): antihypertensive profile and pharmacologyM J Ryan, F A Bjork, D M Cohen, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1984
Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitorM J Ryan, D M Boucher, D M Cohen, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Federation Proceedings|April 1, 1984
Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907M J Ryan, D M Boucher, D M Cohen, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1986
CI-926 (3-[4-[4-(3-methylphenyl)-1-piperazinyl]butyl]-2,4-imidazolinedione): antihypertensive profile and pharmacologyM J Ryan, F A Bjork, D M Cohen, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1984
Antihypertensive effects of CI-907 (indolapril): a novel nonsulfhydryl angiotensin converting enzyme inhibitorM J Ryan, D M Boucher, D M Cohen, et al.
Pageof 4